SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about newspaper publication

21 Nov 2018 Evaluate

In accordance with the requirements of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed about submission of copies of the advertisement of the notice of the 25th Annual General Meeting, E-Voting facility and Book closure of the company published in ‘Business Standard’ and ‘MakkalKural’ newspapers on November 19, 2018.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

565.00 -0.60 (-0.11%)
24-Apr-2026 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.30
Dr. Reddys Lab 1319.40
Cipla 1294.50
Zydus Lifesciences 927.35
Lupin 2295.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×